Clinical Trial Update: Ambulatory Oxygen in Fibrotic Lung Disease (FLD) (AmbOx) [Phase 4]

View source ↗

Summary

This clinical trial update notes that the Ambulatory Oxygen in Fibrotic Lung Disease (AmbOx) study has completed Phase 4.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibrotic Lung Disease

Snippet

Sponsor: Royal Brompton & Harefield NHS Foundation Trust | Conditions: Lung; Disease, Fibroid (Chronic) | Phase 4 | Status: COMPLETED